US Biotech Industry To India’s Modi: Follow Our IP Practices, Get ‘Tidal Wave’ Of Investment 13/01/2017 by William New, Intellectual Property Watch Leave a Comment US Biotechnology Innovation Organization CEO Jim Greenwood told Indian Prime Minister Narendra Modi this week if he follows western practices on intellectual property protection, his country would see a “tidal wave” of biotech industry investment.
US Issues Updated Antitrust Guidelines For Licensing Of IP 13/01/2017 by Intellectual Property Watch 2 Comments The United States Department of Justice and Federal Trade Commission today released updated antitrust guidelines for the licensing of intellectual property.
Panels Present Importance Of Fair Use In South Africa’s Draft Copyright Amendment 13/01/2017 by Linda Daniels for Intellectual Property Watch Leave a Comment CAPE TOWN, South Africa — “Fair use” was at the heart of discussions between intellectual property stakeholders at a recent workshop called to discuss the revised draft copyright amendment bill of South Africa.
ARIPO Lines Up IP Enhancing Activities For 2017 13/01/2017 by Munyaradzi Makoni for Intellectual Property Watch Leave a Comment CAPE TOWN, South Africa – From establishing training schemes, exchange expertise, sharing research, and helping members acquire and develop technology related to intellectual property and shape copyright associated rights, the African Regional Intellectual Property Organization (ARIPO) has set targets for implementation in 2017.
WIPO Green Platform Expanding With Experts Database, Seeks Experts 13/01/2017 by Intellectual Property Watch Leave a Comment The World Intellectual Property Organization internet platform WIPO GREEN is expanding by building a database of experts meant to help technology seekers find green technology specialists to provide their service and expertise.
WEF Davos: Responsible Leadership, Fourth Industrial Revolution, Social Responsibility 13/01/2017 by Catherine Saez, Intellectual Property Watch Leave a Comment Days away from the opening of the annual World Economic Forum in Davos, the founder of the forum described the main themes of the upcoming event, and underlined the role of social responsibility for business leaders.
Research Groups Seek Stronger Protections In EU Copyright Reform Proposal 10/01/2017 by Intellectual Property Watch Leave a Comment European lawmakers should boost protections for researchers and educators in the European Commission proposal for a directive on copyright in the digital single market, five research organisations said today. Among other things, lawmakers and policymakers must rethink the provisions on text and data mining as well as the exception for use of works in digital and cross-border teaching, they said.
Book Review: Interactions Of Climate Change And The Global IP System 10/01/2017 by Catherine Saez, Intellectual Property Watch 1 Comment Climate change is prompting the need for new technologies to address the consequences of the weather changing patterns. A book authored by a number of scholars provides an introduction to the interactions of climate change with the global intellectual property, innovation, human rights and international trade systems.
After 15 Years In WTO, China Still Weak On Many IP Rights Rules, US Says 10/01/2017 by William New, Intellectual Property Watch Leave a Comment Innovation and intellectual property rights have set the United States apart from competitors in recent history, and China seems intent on closing that gap any way it can. A US trade office report out this week on China’s compliance with World Trade Organization rules 15 years after accession show the magnitude of China’s continuing compliance problems related to intellectual property rights.
Expensive Medicines Increase The Pressure 09/01/2017 by Intellectual Property Watch 1 Comment When Gilead brought its new antiviral medicine – Sovaldi – for the treatment of Hepatitis C to the US market for USD 84,000, it triggered a storm of protest. Demand for this revolutionary treatment was so high that the price (despite reductions) became an enormous burden on the American healthcare system. Although the product is cheaper in Switzerland at CHF 48 307, treatment is rationed for reasons of cost.